Maynard Paton | Page 22 | Quality UK Investment Blog

M Winkworth: Credible 2017 Figures Continue To Support 6% Yield Following Yet Another Foxtons-Beating Performance

29 March 2018
By Maynard Paton

Update on M Winkworth (WINK).

Event: Final results for the twelve months to 31 December 2017 published 28 March 2018

Summary: The London estate-agency group was never going to issue stunning figures. Nonetheless, a credible performance was reported and I am impressed the business continues to fare well against sector rival Foxtons. Note, too, that WINK’s average percentage commissions actually increased — so perhaps online competition is not that big a threat after all. Meanwhile, the books remain cash rich, the outlook does not seem too bad while the 10x multiple and 6% yield appear modest. I continue to hold.

S & U: 2018 Results Showcase New Profit High As ‘Sensible Gear Changes’ Set To Control Soaring Bad-Debt Provision

28 March 2018
By Maynard Paton

Update on S & U (SUS).

Event: Preliminary results and presentation for the year to 31 January 2018 published 27 March 2018

Summary: These results from the car-loan specialist once again provided an investment dilemma. True, shareholders received yet another respectable progress report from the accomplished executive team. However, the finer details showed potential bad debts soaring 59% — which was double the growth rate of revenue and customer advances. The chairman is set to make some ‘sensible gear changes’ to keep a lid on potential bad debts, but until the changes become evident, the share-price multiple could be stuck at 13. I continue to hold.

Bioventix: Record H1 Results Show Possible 30% Underlying Revenue Growth Alongside Encouraging Remarks About The New Troponin Product

26 March 2018
By Maynard Paton

Update on Bioventix (BVXP).

Event: Interim results for the six months to 31 December 2017 published 26 March 2018

Summary: The antibody specialist delivered another set of impressive results. I had been concerned about a possible ‘revenue gap’ emerging this year following the termination of certain product income. However, these concerns have now diminished — BVXP’s other sales still seem to be growing fast (I estimate at 30%) while management has become more confident about the early contribution from the new troponin product. The group’s financials remain top class and could even be improved if all of the royalties were collected on time. The 25x multiple is understandable, and I continue to hold.

Mincon: 38% Full-Year Profit Surge Marks ‘First Year Of Current Upturn’ And Prompts A Welcome Lift To The Standstill Dividend

21 March 2018
By Maynard Paton

Update on Mincon (MCON).

Event: Final results for the twelve months ending 31 December 2017 published 20 March 2018

Summary: MCON’s subdued years of 2014, 2015 and 2016 now seem long forgotten after the mining-drill manufacturer confirmed a bumper set of 2017 numbers. Greater client activity has now fuelled director talk of “significant opportunities” and “the first year of the current upturn”, and the share price has naturally climbed to a premium level. Meanwhile, the accounts remain cash-rich, several factors may be suppressing certain ratios, and even the standstill dividend has been lifted. I continue to hold.

FW Thorpe: Record H1 Figures Can’t Disguise Slowing Growth And Elevated 22x Multiple

16 March 2018
By Maynard Paton

Update on FW Thorpe (TFW).

Event: Interim results for the six months to 31 December 2017 published 15 March 2018

Summary: These first-half figures actually set new H1 records, but they also confirmed TFW’s good run of double-digit profit growth will pause during 2018. Pressure on prices for tunnel lighting was cited as one reason for the pedestrian performance. Should revenue and profit continue to plateau, the elevated share price — rated at 22x my earnings guess — may be at risk of a de-rating. Still, the lighting specialist remains a very respectable business, and continues to be led by directors that think long term. I continue to hold.

Tasty: Phew! Not Heading For Bankruptcy Just Yet As £4m Property Proceeds And £1m Underlying Profit Compare To £8m Market Cap

13 March 2018
By Maynard Paton

Update on Tasty (TAST).

Event: Preliminary results for the 52 weeks to 31 December 2017 published 13 March 2018

Summary: Phew! I had thought TAST’s plunging share price was signalling these results would be accompanied by an emergency equity placing. As it turns out, the beleaguered restaurant chain continues to report a profit and has surprised me by raising £4m — equivalent to half of its market cap — from two property transactions. Furthermore, management now has a proper turnaround plan in place, the second half showed a few glimmers of hope while the upside could be considerable if a recovery ever occurs. I have bought more shares, both before and after these results.

Town Centre Securities: 57 Years Of Unbroken Dividends And A Share Price 25% Below NAV

08 March 2018
By Maynard Paton

Today I’m continuing my hunt for Watch List shares by evaluating Town Centre Securities (TOWN).

Here are the initial attractions that prompted this research:

* Illustrious payout history: The business boasts an unbroken 57-year record of dividend payments.

* Substantial long-term shareholders: The founding/managing family boast a sizeable 52%/£78m investment.

* Discount to book value: The 281p shares trade at a 25% discount to the group’s 375p net asset value.

As usual, I’m applying a question-and-answer template to help me pinpoint companies that match the criteria set out in How I Invest. I’m looking for as many Yes answers as possible.

Getech: 17-Month Results Provide Further Hope Of A Profit Rebound And Decent Share-Price Upside

02 March 2018
By Maynard Paton

Update on Getech (GTC).

Event: Final results for the seventeen months to 31 December 2017 published 28 February 2018.

Summary: A change of year end, various exceptional items, the effect of an acquisition and the company’s own ‘cost base’ definition meant studying these numbers was not straightforward. However, it was clear the geoscience software specialist has returned to profit, while it was also obvious the new boss remains confident about the group’s competitive attractions. Looking ahead, I am still hoping some encouraging revenue talk alongside tight cost controls could one day lead to much higher earnings and decent share-price upside. I continue to hold.

Tristel: H1 Results Boast 24% Profit Jump Before North American Costs As EPA Decision Now Set For 16 April

23 February 2018
By Maynard Paton

Update on Tristel (TSTL).

Event: Interim results and shareholder presentation for the six months to 31 December 2017 published 20 February 2018

Summary: These first-half figures were slightly better than I had expected, with December’s AGM statement having downplayed the group’s underlying progress. Welcome revenue advances — both in the UK and abroad — were delivered by TSTL’s main disinfectant products, while adjusted profit would have soared 24% were it not for the costs of entering North America. Sadly it remains anyone’s guess as to when those costs will eventually see any payback. Nonetheless, the first North American milestone is looming — an EPA product approval decision is expected on 16 April, and the share price is optimistic. I continue to hold.

James Latham: The Family Owns 50%-Plus And Has Delivered 10% Long-Term Dividend Growth

15 February 2018
By Maynard Paton

Today I’m re-starting my hunt for Watch List shares with a look at James Latham (LTHM).

Here are the initial attractions that prompted this research:

* Owner-friendly management: The Latham family has £75m-plus riding on the share price and appear to run the business in a sensible (and LTIP-free) manner.

* Respectable track record: Recent decades of the group’s 261-year history have witnessed average dividend growth of approximately 10% a year.

* Asset-rich accounts: The books boast a sizeable cash position, freehold assets and a share count that has not changed since at least 1994.

As usual, I’m applying a question-and-answer template to help me pinpoint companies that match the criteria set out in How I Invest. I’m looking for as many Yes answers as possible.

City Of London Investment: Market Gains Deliver Best-Ever H1 As Increased Dividend Supports 6% Yield

19 January 2018
By Maynard Paton

Update on City of London Investment (CLIG).

Event: Trading update and shareholder presentation/summary results for the six months ending 31 December 2017 published 17 January 2018.

Summary: Favourable market movements helped CLIG report its best-ever first-half figures, with revenue, profit, net cash and the dividend all moving higher. However, the finer details showed the emerging-market fund manager struggling to capture new clients as its main strategy under-performed. Meanwhile, fee rates are still being chipped away and staff costs keep on climbing. The shares may look under-appreciated on a P/E of 10 and yield of 6%, but sadly a re-rating does not appear imminent. I continue to hold.

Q4 2017: 2 Top-Ups And Up 10.5% For 2017

01 January 2018
By Maynard Paton

Happy 2018! I trust you have enjoyed a successful year’s investing and that you continue to find my Blog useful.

I’m currently celebrating my third anniversary as a full-time investor — and I am reasonably satisfied with how things have turned out so far.

Indeed, with no income other than my capital gains and dividends, I am pleased my portfolio has recorded a positive performance during each of the last three years.

However, the three years have not been all plain sailing. In particular, I did wonder whether foregoing an annual salary was such a bright idea during the mid-2016 Brexit lows. Still, a recovery eventually emerged that has continued throughout 2017.

All that said, I’m disappointed to have under-performed the market for the second consecutive year. Unfortunately for me, a decent collection of 2017 portfolio winners was counterbalanced by one big loser.

Let me explain what happened.

My Portfolio: Year In Review 2017

01 January 2018
By Maynard Paton

Happy New Year!

I trust you have enjoyed the festive break and are now raring to do battle with the market for another twelve months!

This first Blog post of 2018 provides a ‘year in review’ of my current portfolio holdings. I recap how each of the underlying businesses performed during 2017, as well as provide a few remarks about valuation.

Daejan: NAV Creeps To New £103 Per Share High And I Now Wonder Whether I Should Buy Once More

29 November 2017
By Maynard Paton

Update on Daejan (DJAN).

Event: Interim results for the six months to 30 September 2017 published 29 November 2017

Summary: From what I could tell from the chairman’s 216-word update, DJAN has had to work hard of late to achieve somewhat modest progress. Currency movements and Brexit apparently kept a lid on this H1 performance, although NAV still managed to creep to a £103 per share all-time high. Dull updates from low-profile businesses often cause share prices to stagnate, and so I’m not too surprised the property group’s discount to book has widened since I first bought during 2015. I now wonder whether I should buy once again. I continue to hold.

Mountview Estates: NAV Reaches Fresh £89 Per Share High Despite Weakest H1 For 4 Years

23 November 2017
By Maynard Paton

Update on Mountview Estates (MTVW).

Event: Interim results for the six months to 30 September 2017 published 23 November 2017

Summary: It took MTVW’s chief exec just 265 words to describe the group’s weakest first-half performance for four years. Still, the nature of this property-trading firm means earnings can be somewhat variable from time to time. What is important, though, is that net asset value improved once again to a fresh high while debt continues to be reduced to a new low. My sums point to a possible NAV of £209 per share based on the firm’s long-term margin. I continue to hold.

Maynard Paton: “System1 (SYS1) Publication of 2024 annual report (continued) Here are more points of interest beyond those noted in the blog…” 25 May 2025

Maynard Paton: “System1 (SYS1) Publication of 2024 annual report Here are the points of interest beyond those noted in the blog post…” 24 May 2025

Maynard Paton: “Well, this is a consultancy and shareholders are arguably left with whatever the partner consultants have not demanded for themselves…” 23 May 2025

Joe: “Understood, I think it’s one I would need to spend more time figuring out whether the company is run for…” 23 May 2025

Maynard Paton: “Hi Joe Yes, perfectly valid to adjust the share count for the options instead of treating the EBT purchases as…” 22 May 2025

Joe: “Hi Maynard, With regard to Elixirr’s £18m EBT expense – rather than deducting it as an expense to get to…” 22 May 2025

Maynard Paton: “Hi Charles, Both messages received — not sure about the ‘critical error’. Maybe my spam filter was playing up :-(…” 02 May 2025

Maynard Paton: “Mountview Estates (MTVW) Result of General Meeting published 18 November 2024 and Directorate Change published 19 November 2024   I…” 02 May 2025